Single-cell Polyfunctional Proteomics of CD4 Cells from Patients with AML Predicts Responses to Anti-PD-1-based therapyJillian Romeo2021-09-30T13:35:11-04:00
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trialJillian Romeo2021-07-27T10:37:57-04:00
Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activationJillian Romeo2021-07-26T18:16:43-04:00
Synchronous effects of targeted mitochondrial complex I inhibitors on tumor and immune cells abrogate melanoma progressionJillian Romeo2021-08-10T15:44:01-04:00